Impact of spread through air spaces (STAS) and lymphovascular invasion (LVI) on prognosis in NSCLC: a comprehensive pathological evaluation

• by Can Kutlay, Selim Şakir Erkmen Gülhan, Leyla Nesrin Acar, Muhyettin Aslan, Fatma Benli Tanrıkulu

• April 9, 2025

Study Led by Roswell Park’s Dr. Sai Yendamuri Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes

Lung cancer patients who take medications called GLP-1 receptor agonists — commonly prescribed for weight loss and diabetes management — fare better than those who don’t, according to research.

• by

• September 15, 2025

• 3 min

Perioperative Outcomes of Robot-Assisted versus Video-Assisted Thoracoscopic Surgery for Non-Small Cell Lung Cancer: A Meta-Analysis Focusing on Real-World Clinical Studies in the Past 10 Years

• by Zhu, Jianfang , Meng, Xiaopeng , Hu, Liyong

• April 27, 2026

Editorial: Clinical and surgical perspectives in sublobar resection for lung cancer

• by Takuya Fujita

• April 1, 2026